Biological Activity
AEE788 is an orally bioavailable multiple-receptor tyrosine kinase inhibitor that inhibits phosphorylation of the tyrosine kinases of EGFR, HER2 and VEGF2.
Targets
Target | Value |
---|---|
EGFR | IC50: 2nM |
HER2/ErbB2 | IC50: 6nM |
c-Abl | IC50: 52nM |
FLT1 | IC50: 59nM |
c-Fms | IC50: 60nM |
c-Src | IC50: 61nM |
KDR | IC50: 77nM |
HER4/ErbB4 | IC50: 160nM |
PDGFRβ | IC50: 320nM |
FLT4 | IC50: 330nM |
FLT3 | IC50: 730nM |
RET | IC50: 740nM |
c-Kit | IC50: 790nM |
Tek | IC50: 2.1μM |
C-Raf-1 | IC50: 2.8μM |
c-Met | IC50: 2.9μM |
CDK1/CyclinB | IC50: 8.0μM |
IGF-1R | IC50: >10μM |
Insulin Receptor | IC50: >10μM |
PKCα | IC50: >10μM |
PKA | IC50: >10μM |
In vitro (25°C) | DMSO | 81 mg/mL (183.84 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.7 mL | 113.48 mL | 226.96 mL |
0.5 mM | 4.54 mL | 22.7 mL | 45.39 mL |
1 mM | 2.27 mL | 11.35 mL | 22.7 mL |
5 mM | 0.45 mL | 2.27 mL | 4.54 mL |
*The above data is based on the productmolecular weight 440.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A10043 |
---|---|
Actions | Inhibitor |
CAS No. | 497839-62-0 |
Formula | C27H32N6 |
M. Wt | 440.6 |
Purity | >98% |
Synonyms | AEE-788, NVP-AEE788 |
SMILES | CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4N[[email protected]](C)C5=CC=CC=C5 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Pelitinib (EKB-569)
Pelitinib (EKB-569) is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity.
XL647 (Tesevatinib)
XL647 is an orally bioavailable small-molecule RTK inhibitor that binds to and inhibits several tyrosine receptor kinases that play major ro…
CL-387785 (EKI-785)
CL-387785 is an irreversible inhibitor of EGFR with IC50 of 370+/-120 pM; is able to overcome resistance caused by the T790M mutation on a f…
AG-1478 (Tyrphostin AG-1478)
AG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
PKC 412 (Midostaurin)
PKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms α/β/γ, PDFRβ, VEGFR2, Syk, Flk-1, Flt3, Cdk1/B,…
AV-412
AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth factor receptor (EGFR) and the human epidermal growth facto…
AZD3759
AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR). It binds to and inhibits the activity of EGFR as we…
Gefitinib (Iressa)
Gefitinib is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.
Keywords:buy AEE788 | AEE788 Supplier | purchase | cost | manufacturer | order | distributor | buy 497839-62-0| 497839-62-0 Supplier | purchase 497839-62-0 | 497839-62-0 cost | 497839-62-0 manufacturer | order 497839-62-0 | 497839-62-0 distributor